From Drug Discovery to Drug Approval: A Comprehensive Review of the Pharmacogenomics Status Quo with a Special Focus on Egypt

• المؤلفون الرئيسيون: Fadya M. Elgarhy (مؤلف), Abdallah Borham (مؤلف), Noha Alziny (مؤلف), Khlood R. AbdElaal (مؤلف), Mahmoud Shuaib (مؤلف), Abobaker Salem Musaibah (مؤلف), Mohamed Ali Hussein (مؤلف), Anwar Abdelnaser (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2024-07-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Pharmacogenomics (PGx) is the hope for the full optimization of drug therapy while minimizing the accompanying adverse drug events that cost billions of dollars annually. Since years before the century, it has been known that inter-individual variations contribute to differences in specific drug res...